CACCESE, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 474
EU - Europa 434
AS - Asia 245
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 1.157
Nazione #
US - Stati Uniti d'America 474
CN - Cina 174
GB - Regno Unito 154
IE - Irlanda 62
SE - Svezia 52
SG - Singapore 48
RU - Federazione Russa 47
IT - Italia 35
DE - Germania 34
FR - Francia 31
FI - Finlandia 6
KR - Corea 6
UA - Ucraina 6
ID - Indonesia 3
JP - Giappone 3
VN - Vietnam 3
AU - Australia 2
CH - Svizzera 2
IR - Iran 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IN - India 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
RO - Romania 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 1.157
Città #
Chandler 170
Southend 146
Dublin 62
Singapore 43
Woodbridge 33
Beijing 30
Ashburn 23
Houston 23
Ann Arbor 18
Jacksonville 18
Shenyang 18
Jinan 15
New York 15
Lawrence 14
Princeton 14
Nanjing 13
Verona 13
Wilmington 13
Tianjin 12
Guangzhou 7
Hebei 6
Ningbo 6
Seoul 6
Siegen 6
Moscow 5
Sindelfingen 5
Taizhou 5
Zhengzhou 5
Hangzhou 4
Nanchang 4
Augusta 3
Detroit 3
Jakarta 3
Lancaster 3
Redmond 3
Taiyuan 3
Tokyo 3
Changsha 2
Fuzhou 2
Haikou 2
London 2
Munich 2
Norwalk 2
Redwood City 2
Rome 2
Seattle 2
Sossano 2
Adliswil 1
Ardabil 1
Athens 1
Austin 1
Baku 1
Bangkok 1
Bergamo 1
Boardman 1
Bologna 1
Brno 1
Buffalo 1
Böblingen 1
Cascina 1
Cattolica 1
Des Moines 1
Dong Ket 1
Dongguan 1
Dubai 1
Fairfield 1
Fremont 1
Kashan 1
Kent 1
Los Angeles 1
Mehlingen 1
Melbourne 1
Negrar 1
Newark 1
Nürnberg 1
Phoenix 1
Riva 1
San Francisco 1
Sant'Ambrogio di Valpolicella 1
Santa Clara 1
Santiago Metropolitan 1
Sofia 1
Sydney 1
Tashkent 1
Vienna 1
Vientiane 1
Washington 1
Xi'an 1
Zurich 1
Totale 835
Nome #
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 120
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 119
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer 110
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 97
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives 95
Tubulin inhibitors in non-small cell lung cancer: looking back and forward 91
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 88
A molecular signature associated with prolonged survival in glioblastoma patients treated with Regorafenib 82
Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system. 74
Do immune checkpoint inhibitors need new studies methodology? 69
Adjuvant therapy for resected early-stage small-cell lung cancer: is now time to rethink about that? 65
Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies 63
Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study 56
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study 50
Totale 1.179
Categoria #
all - tutte 4.162
article - articoli 3.842
book - libri 0
conference - conferenze 320
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202079 0 0 0 0 12 10 15 3 11 8 3 17
2020/2021114 18 11 16 16 11 5 2 2 0 5 21 7
2021/2022127 10 54 2 1 12 1 1 6 2 2 2 34
2022/2023371 16 47 14 99 28 92 1 25 43 0 2 4
2023/2024132 6 16 7 11 15 27 4 10 4 15 13 4
2024/2025125 15 17 22 64 7 0 0 0 0 0 0 0
Totale 1.179